Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | +5.82% | +7.68% | -24.35% |
Apr. 10 | Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer | CI |
Mar. 27 | UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating | MT |
Business Summary
Number of employees: 66
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amy Burroughs
CEO | Chief Executive Officer | 53 | Feb. 06 |
Erin Quirk
PSD | President | 53 | 18-12-31 |
Mark Vignola
DFI | Director of Finance/CFO | 46 | 20-08-10 |
Bryan Yoon
COO | Chief Operating Officer | 47 | 20-10-31 |
Chief Tech/Sci/R&D Officer | - | 22-01-05 | |
Justin Ng
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | 44 | 23-04-30 | |
Melita Sun Jung
PRN | Corporate Officer/Principal | 46 | Apr. 21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Fellows
CHM | Chairman | 67 | 20-11-30 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 20-11-30 |
Carl Gordon
BRD | Director/Board Member | 59 | 18-09-30 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 20-03-31 |
Director/Board Member | 44 | 22-07-25 | |
Jill Quigley
BRD | Director/Board Member | 48 | 20-11-30 |
Amy Burroughs
CEO | Chief Executive Officer | 53 | Feb. 06 |
Erin Quirk
PSD | President | 53 | 18-12-31 |
Ann Taylor
BRD | Director/Board Member | - | 21-09-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,651,693 | 62,374,818 ( 96.48 %) | 0 | 96.48 % |
Company contact information
Terns Pharmaceuticals, Inc.
1065 East Hillsdale Boulevard Suite 100
94404, Foster City
+650 525 5535
http://www.ternspharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.35% | 318M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TERN Stock
- Company Terns Pharmaceuticals, Inc.